Donald L. Hagan LLC’s Marker Therapeutics MRKR Stock Holding History

Donald L. Hagan LLC’s Portfolio MRKR Stock Details MRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,000	Closed	-$94K	–	88
2018 Q2	$94K	Buy	+1,000	New	+$51K	0.08%	81

Other funds holding MRKR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

NRS

Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return

Donald L. Hagan LLC's MRKR Position: Q3 2018 in Review

Donald L. Hagan LLC sold out of Marker Therapeutics (MRKR) in Q3 2018, closing a stake of 1,000 shares — an estimated $94K sold.

Donald L. Hagan LLC first reported a position in MRKR in Q2 2018 and held it in 1 quarter. The position peaked at $94K in Q2 2018. 31 funds tracked by Wall St. Rank hold MRKR as of Q3 2018.

Donald L. Hagan LLC reported no remaining Marker Therapeutics position as of Q3 2018 after selling out during the quarter.
Donald L. Hagan LLC sold 1,000 Marker Therapeutics shares in Q3 2018, an estimated $94K.
Donald L. Hagan LLC first reported a position in Marker Therapeutics in Q2 2018 and held it in 1 quarter.
Donald L. Hagan LLC's Marker Therapeutics position peaked at $94K in Q2 2018.
31 funds tracked by Wall St. Rank held Marker Therapeutics as of Q3 2018.

Based on Donald L. Hagan LLC's 13F filing for Q3 2018, filed 22 Oct 2018.